Collectively, this study demonstrates that the long-term use of CSII therapy (insulinization) mimics physiological insulin secretion more effectively than other treatment strategies and provides a promising strategy for the treatment of diabetes mellitus type 2. The gene discussed is INS; the disease is diabetes mellitus.